Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care.

@article{Obrien1998AssessingTV,
  title={Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care.},
  author={Bernie J O'brien and Ron Goeree and Amiram Gafni and George W. Torrance and M. Kate Bundorf Mark V. Pauly and Haim Erder and James Rusthoven and Jane Weeks and Michael C Cahill and Bart Lamont},
  journal={Medical care},
  year={1998},
  volume={36 3},
  pages={370-84}
}
OBJECTIVES The authors assessed the feasibility and construct validity of the contingent valuation method for measuring the monetary value to healthy enrollees in a health maintenance organization of a new drug, filgrastim, as prophylaxis against febrile neutropenia after chemotherapy treatment for cancer. METHODS A random sample of 220 enrollees from a closed-panel staff-model health maintenance organization who did not have cancer were interviewed. Chemotherapy, febrile neutropenia and… CONTINUE READING

From This Paper

Topics from this paper.
40 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 40 extracted citations

Similar Papers

Loading similar papers…